The European Commission approved the drug, an oral solution containing highly purified plant-derived cannabidiol, for use in adjunctive therapy of seizures associated with Lennox-Gastaut syndrome ...

Artelo Biosciences (ARTL) announced nonclinical results on ART12.11, its proprietary cocrystal composition of cannabidiol and ...

Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical ...

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti ...

Medical marijuana consists primarily of chemical compounds called cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), and others like terpenes. The THC cannabinoid is the ...